<Version>
  <xmlSource>This XML content was developed by AHRQ's contractor ECRI Institute for the National Guideline Clearinghouse (NGC).</xmlSource>
  <Section SecID="390" OrdBy="100" Name="General">
    <Field FieldID="161" OrdBy="105" ID="391" Name="Guideline Title" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_title&quot;&gt;Knee stability and movement coordination impairments: knee ligament sprain revision 2017.&lt;/div&gt;" />
    </Field>
    <Field FieldID="97" OrdBy="110" ID="392" Name="Bibliographic Source(s)" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Logerstedt DS, Scalzitti D, Risberg MA, Engebretsen L, Webster KE, Feller J, Snyder-Mackler L, Axe MJ, McDonough CM. Knee stability and movement coordination impairments: knee ligament sprain revision 2017. J Orthop Sports Phys Ther. 2017 Nov;47(11):A1-A47. [129 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=29089004 &quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
    <Field FieldID="120" OrdBy="115" ID="393" Name="Guideline Status" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xA;&lt;p&gt;This guideline update a previous version: Logerstedt DS, Snyder-Mackler L, Ritter RC, Axe MJ, Godges JJ, Orthopaedic Section of the American Physical Therapist Association. Knee stability and movement coordination impairments: knee ligament sprain. J Orthop Sports Phys Ther. 2010 Apr;40(4):A1-A37. [175 references]. &lt;/p&gt;&#xA;&lt;p&gt;This guideline meets NGC's 2013 (revised) inclusion criteria.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="705" OrdBy="150" Name="NEATS Assessment">
    <Field FieldID="183" OrdBy="10" ID="706" Name="Disclosure of Guideline Funding Source" Type="picklist-one">
      <FieldValue Value="Yes" />
    </Field>
    <Field FieldID="184" OrdBy="20" ID="707" Name="Disclosure and Management of Financial Conflict of Interests" Type="picklist-one">
      <FieldValue Value="3" />
    </Field>
    <Field FieldID="185" OrdBy="30" ID="708" Name="Guideline Development Group Composition: Multidisciplinary Group" Type="picklist-one">
      <FieldValue Value="Yes" />
    </Field>
    <Field FieldID="186" OrdBy="40" ID="709" Name="Guideline Development Group Composition: Methodologist Involvement" Type="picklist-one">
      <FieldValue Value="Yes" />
    </Field>
    <Field FieldID="187" OrdBy="50" ID="710" Name="Guideline Development Group Composition: Patient and Public Perspectives" Type="picklist-one">
      <FieldValue Value="4" />
    </Field>
    <Field FieldID="188" OrdBy="60" ID="711" Name="Use of a Systematic Review of Evidence: Search Strategy" Type="picklist-one">
      <FieldValue Value="5" />
    </Field>
    <Field FieldID="189" OrdBy="70" ID="712" Name="Use of a Systematic Review of Evidence: Study Selection" Type="picklist-one">
      <FieldValue Value="5" />
    </Field>
    <Field FieldID="190" OrdBy="80" ID="713" Name="Use of a Systematic Review of Evidence: Synthesis of Evidence" Type="picklist-one">
      <FieldValue Value="5" />
    </Field>
    <Field FieldID="191" OrdBy="90" ID="714" Name="Evidence Foundations for and Rating Strength of Recommendations: Grading the Quality or Strength of Evidence" Type="picklist-one">
      <FieldValue Value="4" />
    </Field>
    <Field FieldID="192" OrdBy="100" ID="715" Name="Evidence Foundations for and Rating Strength of Recommendations: Benefits and Harms of Recommendations" Type="picklist-one">
      <FieldValue Value="4" />
    </Field>
    <Field FieldID="193" OrdBy="110" ID="716" Name="Evidence Foundations for and Rating Strength of Recommendations: Evidence Summary Supporting Recommendations" Type="picklist-one">
      <FieldValue Value="5" />
    </Field>
    <Field FieldID="194" OrdBy="120" ID="717" Name="Evidence Foundations for and Rating Strength of Recommendations: Rating the Strength of Recommendations" Type="picklist-one">
      <FieldValue Value="4" />
    </Field>
    <Field FieldID="195" OrdBy="130" ID="718" Name="Specific and Unambiguous Articulation of Recommendations" Type="picklist-one">
      <FieldValue Value="5" />
    </Field>
    <Field FieldID="196" OrdBy="140" ID="719" Name="External Review" Type="picklist-one">
      <FieldValue Value="5" />
    </Field>
    <Field FieldID="197" OrdBy="150" ID="720" Name="Updating" Type="picklist-one">
      <FieldValue Value="5" />
    </Field>
  </Section>
  <Section SecID="420" OrdBy="300" Name="Recommendations">
    <Field FieldID="151" OrdBy="310" ID="421" Name="Major Recommendations" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Levels of evidence (&lt;strong&gt;I&amp;ndash;V&lt;/strong&gt;) and grades of recommendation (&lt;strong&gt;A&amp;ndash;F&lt;/strong&gt;) are defined at the end of the &quot;Major Recommendations&quot; field.&lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;&lt;strong&gt;Note&lt;/strong&gt;: These recommendations and clinical practice guidelines are based on the scientific literature published prior to December 2016. &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Diagnosis/Classification&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Physical therapists should diagnose the International Classification of Diseases (ICD) categories of Sprain and strain involving collateral ligament of knee, Sprain and strain involving cruciate ligament of knee, and Injury to multiple structures of knee, and the associated International Classification of Functioning, Disability and Health (ICF) impairment-based categories of knee instability (b7150 Stability of a single joint) and movement coordination impairments (b7601 Control of complex voluntary movements), using the following history and physical examination findings: mechanism of injury, passive knee laxity, joint pain, joint effusion, and movement coordination impairments. (&lt;strong&gt;Grade of Recommendation: A&lt;/strong&gt;) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Differential Diagnosis&lt;/strong&gt;&lt;/span&gt; &lt;/p&gt;&#xD;&#xA;&lt;p&gt;The clinician should suspect diagnostic classifications associated with serious pathological conditions when the individual's reported activity limitations and impairments of body function and structure are not consistent with those presented in the Diagnosis/Classification section of this guideline, or when the individual's symptoms are not resolving with intervention aimed at normalization of the individual's impairments of body function. (&lt;strong&gt;Grade of Recommendation: B&lt;/strong&gt;) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Examination&lt;/strong&gt;&lt;/span&gt; &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Outcome Measures: Activity Limitations and Self-Reported Measures&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Clinicians should use the International Knee Documentation Committee 2000 Subjective Knee Evaluation Form (IKDC 2000) or Knee injury and Osteoarthritis Outcome Score (KOOS), and may use the Lysholm scale, as validated patient-reported outcome measures to assess knee symptoms and function, and should use the Tegner activity scale or Marx Activity Rating Scale to assess activity level, before and after interventions intended to alleviate the physical impairments, activity limitations, and participation restrictions associated with knee ligament sprain. Clinicians may use the Anterior Cruciate Ligament-Return to Sport after Injury (ACL-RSI) instrument as a validated patient-reported outcome measure to assess psychological factors that may hinder return to sports before and after interventions intended to alleviate fear of reinjury associated with knee ligament sprain. (&lt;strong&gt;Grade of Recommendation: B&lt;/strong&gt;) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Physical Performance Measures&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Clinicians should administer appropriate clinical or field tests, such as single-legged hop tests (e.g., single hop for distance, crossover hop for distance, triple hop for distance, and 6-meter timed hop), that can identify a patient's baseline status relative to pain, function, and disability; detect side-to-side asymmetries; assess global knee function; determine a patient's readiness to return to activities; and monitor changes in the patient's status throughout the course of treatment. (&lt;strong&gt;Grade of Recommendation: B&lt;/strong&gt;) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Physical Impairment Measures&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;When evaluating a patient with ligament sprain over an episode of care, clinicians should use assessments of impairment of body structure and function, including measures of knee laxity/stability, lower-limb movement coordination, thigh muscle strength, knee effusion, and knee joint range of motion. (&lt;strong&gt;Grade of Recommendation: B&lt;/strong&gt;) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Interventions&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Continuous Passive Motion&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Clinicians may use continuous passive motion in the immediate postoperative period to decrease postoperative pain after anterior cruciate ligament (ACL) reconstruction. (&lt;strong&gt;Grade of Recommendation: C&lt;/strong&gt;) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Early Weight Bearing&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Clinicians may implement early weight bearing as tolerated (within 1 week after surgery) for patients after ACL reconstruction. (&lt;strong&gt;Grade of Recommendation: C&lt;/strong&gt;) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Knee Bracing&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Clinicians may use functional knee bracing in patients with ACL deficiency. (&lt;strong&gt;Grade of Recommendation: C&lt;/strong&gt;) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;Clinicians should elicit and document patient preferences in the decision to use functional knee bracing following ACL reconstruction, as evidence exists for and against its use. (&lt;strong&gt;Grade of Recommendation: D&lt;/strong&gt;) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;Clinicians may use appropriate knee bracing for patients with acute posterior cruciate ligament (PCL) injuries, severe medial collateral ligament (MCL) injuries, or posterolateral corner (PLC) injuries. (&lt;strong&gt;Grade of Recommendation: F&lt;/strong&gt;) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Immediate Versus Delayed Mobilization&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Clinicians should use immediate mobilization (within 1 week) after ACL reconstruction to increase joint range of motion, reduce joint pain, and reduce the risk of adverse responses of surrounding soft tissue structures, such as those associated with knee extension range-of-motion loss. (&lt;strong&gt;Grade of Recommendation: B&lt;/strong&gt;) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Cryotherapy&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Clinicians should use cryotherapy immediately after ACL reconstruction to reduce postoperative knee pain. (&lt;strong&gt;Grade of Recommendation: B&lt;/strong&gt;) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Supervised Rehabilitation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Clinicians should use exercises as part of the in-clinic supervised rehabilitation program after ACL reconstruction and should provide and supervise the progression of a home-based exercise program, providing education to ensure independent performance. (&lt;strong&gt;Grade of Recommendation: B&lt;/strong&gt;) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Therapeutic Exercises&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Weight-bearing and non&amp;ndash;weight-bearing concentric and eccentric exercises should be implemented within 4 to 6 weeks, 2 to 3 times per week for 6 to 10 months, to increase thigh muscle strength and functional performance after ACL reconstruction. (&lt;strong&gt;Grade of Recommendation: A&lt;/strong&gt;) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Neuromuscular Electrical Stimulation&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Neuromuscular electrical stimulation should be used for 6 to 8 weeks to augment muscle strengthening exercises in patients after ACL reconstruction to increase quadriceps muscle strength and enhance short-term functional outcomes. (&lt;strong&gt;Grade of Recommendation: A&lt;/strong&gt;) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Neuromuscular Re-Education&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Neuromuscular re-education training should be incorporated with muscle strengthening exercises in patients with knee stability and movement coordination impairments. (&lt;strong&gt;Grade of Recommendation: A&lt;/strong&gt;)&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Definitions&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Levels of Evidence&lt;/strong&gt;*&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;3&quot; cellpadding=&quot;5&quot; summary=&quot;Table: Levels of Evidence&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Level&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Intervention/Prevention&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Pathoanatomic/Risk/Clinical Course/Prognosis/Differential Diagnosis&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Diagnosis/Diagnostic Accuracy&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Prevalence of Condition/Disorder&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Exam/Outcomes&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;row&quot;&gt;&lt;strong&gt;I&lt;/strong&gt;&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of high-quality RCTs &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality RCT&lt;sup&gt;&amp;dagger;&lt;/sup&gt; &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of prospective cohort studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality prospective cohort study&lt;sup&gt;&amp;Dagger;&lt;/sup&gt; &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of high-quality diagnostic studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality diagnostic study&lt;sup&gt;&amp;sect;&lt;/sup&gt; with validation &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR, high-quality cross-sectional studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality cross-sectional study&lt;sup&gt;â &lt;/sup&gt;&lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of prospective cohort studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality prospective cohort study &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;row&quot;&gt;&lt;strong&gt;II&lt;/strong&gt;&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of high-quality cohort studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality cohort study&lt;sup&gt;&amp;Dagger;&lt;/sup&gt; &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Outcomes study or ecological study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Lower-quality RCT&lt;sup&gt;&amp;para;&lt;/sup&gt; &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of retrospective cohort study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Lower-quality prospective cohort study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality retrospective cohort study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Consecutive cohort &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Outcomes study or ecological study &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of exploratory diagnostic studies or consecutive cohort studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality exploratory diagnostic studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Consecutive retrospective cohort &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of studies that allows relevant estimate &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Lower-quality cross-sectional study &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of lower-quality prospective cohort studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Lower-quality prospective cohort study &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;row&quot;&gt;&lt;strong&gt;III &lt;/strong&gt;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SRs of case-control studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality case-control study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Lower-quality cohort study &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Lower-quality retrospective cohort study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality cross-sectional case-control study &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Lower-quality exploratory diagnostic studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Nonconsecutive retrospective cohort &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Local nonrandom study&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;High-quality cross-sectional study&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;row&quot;&gt;&lt;strong&gt;IV&lt;/strong&gt;&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Case series&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Case series&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Case-control study&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;--&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Lower-quality cross-sectional study&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;row&quot;&gt;&lt;strong&gt;V&lt;/strong&gt;&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Expert opinion&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Expert opinion&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Expert opinion&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Expert opinion&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Expert opinion&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;Abbreviations: RCT, randomized clinical trial; SR, systematic review. &lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;*Adapted from Phillips B, Ball C, Sackett D, et al. Oxford Centre for Evidence-based Medicine - Levels of Evidence (March 2009). Available at: &lt;a href=&quot;http://www.cebm.net/index.aspx?o=1025&quot; title=&quot;Center for Evidence Based Medicine Web site&quot;&gt;http://www.cebm.net/index.aspx?o=1025&lt;/a&gt;. See also Appendix G in the original guideline document.&lt;br /&gt;&#xD;&#xA;&amp;dagger;High quality includes RCTs with greater than 80% follow-up, blinding, and appropriate randomization procedures.&lt;br /&gt;&#xD;&#xA;&amp;Dagger;High-quality cohort study includes greater than 80% follow-up.&lt;br /&gt;&#xD;&#xA;&amp;sect;High-quality diagnostic study includes consistently applied reference standard and blinding.&lt;br /&gt;&#xD;&#xA;âHigh-quality prevalence study is a cross-sectional study that uses a local and current random sample or censuses.&lt;br /&gt;&#xD;&#xA;&amp;para;Weaker diagnostic criteria and reference standards, improper randomization, no blinding, and less than 80% follow-up may add bias and threats to validity.&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;Grades of Recommendation Based on Strength of Evidence&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;3&quot; cellpadding=&quot;5&quot; summary=&quot;Table: Grades of Recommendation&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; colspan=&quot;2&quot; scope=&quot;col&quot;&gt;Grades of Recommendation Based On&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Strength of Evidence&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;A&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Strong evidence&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A preponderance of level I and/or level II studies support the recommendation. This must include at least 1 level I study&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;B&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Moderate evidence&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A single high-quality randomized controlled trial or a preponderance of level II studies support the recommendation&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;C&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Weak evidence&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A single level II study or a preponderance of level III and IV studies, including statements of consensus by content experts, support the recommendation&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;D&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Conflicting evidence&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Higher-quality studies conducted on this topic disagree with respect to their conclusions. The recommendation is based on these conflicting studies&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;E&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Theoretical/foundational evidence&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A preponderance of evidence from animal or cadaver studies, from conceptual models/principles, or from basic sciences/bench research support this conclusion&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;F&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Expert opinion&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Best practice based on the clinical experience of the guidelines development team&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="138" OrdBy="330" ID="423" Name="Clinical Algorithm(s)" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;None provided&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="396" OrdBy="400" Name="Scope">
    <Field FieldID="140" OrdBy="405" ID="397" Name="Disease/Condition(s)" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Knee stability and movement coordination impairments associated with knee ligament sprain&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="103" OrdBy="410" ID="398" Name="Guideline Category" Type="picklist-many">
      <FieldValue Value="Diagnosis" />
      <FieldValue Value="Evaluation" />
      <FieldValue Value="Management" />
      <FieldValue Value="Rehabilitation" />
      <FieldValue Value="Treatment" />
    </Field>
    <Field FieldID="113" OrdBy="415" ID="399" Name="Clinical Specialty" Type="picklist-many">
      <FieldValue Value="Family Practice" />
      <FieldValue Value="Orthopedic Surgery" />
      <FieldValue Value="Physical Medicine and Rehabilitation" />
      <FieldValue Value="Rheumatology" />
      <FieldValue Value="Sports Medicine" />
    </Field>
    <Field FieldID="114" OrdBy="420" ID="400" Name="Intended Users" Type="picklist-many">
      <FieldValue Value="Health Care Providers" />
      <FieldValue Value="Physical Therapists" />
      <FieldValue Value="Physician Assistants" />
      <FieldValue Value="Physicians" />
      <FieldValue Value="Students" />
      <FieldValue Value="Utilization Management" />
    </Field>
    <Field FieldID="129" OrdBy="425" ID="401" Name="Guideline Objective(s)" Type="text">
      <FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;To describe evidence-based physical therapy practice, including diagnosis, prognosis, intervention, and assessment of outcome for musculoskeletal disorders commonly managed by orthopaedic and sports physical therapists &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To classify and define common musculoskeletal conditions using the World Health Organization's terminology related to impairments of body function and body structure, activity limitations, and participation restrictions &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To identify interventions supported by current best evidence to address impairments of body function and structure, activity limitations, and participation restrictions associated with common musculoskeletal conditions &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To identify appropriate outcome measures to assess changes resulting from physical therapy interventions in body function and structure as well as in activity and participation of the individual &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To provide a description to policy makers, using internationally accepted terminology, of the practice of orthopaedic physical therapists &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To provide information for payers and claims reviewers regarding the practice of orthopaedic physical therapy for common musculoskeletal conditions &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;To create a reference publication for orthopaedic physical therapy clinicians, academic instructors, clinical instructors, students, interns, residents, and fellows regarding the best current practice of orthopaedic physical therapy &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" />
    </Field>
    <Field FieldID="132" OrdBy="430" ID="402" Name="Target Population" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Adult patients with knee stability and movement coordination impairments/knee ligament sprain&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="133" OrdBy="435" ID="403" Name="Interventions and Practices Considered" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Diagnosis&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Diagnosis and classification according to International Statistical Classification of Diseases and Related Health Problems (ICD) criteria and International Classification of Functioning, Disability, and Health (ICF) criteria &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Differential diagnosis &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Examination using validated outcome measures: activity limitations and self-reported measures&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;International Knee Documentation Committee 2000 Subjective Knee Evaluation Form (IKDC 2000) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Knee injury and Osteoarthritis Outcome Score (KOOS) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Lysholm scale &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Tegner activity scale &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Marx Activity Rating Scale &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Anterior Cruciate Ligament-Return to Sport after Injury (ACL-RSI) instrument &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Examination using physical performance measures:&amp;nbsp;single-legged hop tests (single hop for distance, crossover hop for distance, triple hop for distance, 6-meter timed hop) &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Examination using physical impairment measures (i.e., knee laxity/stability, lower-limb movement coordination, thigh muscle strength, knee effusion, and knee joint range of motion) &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&#xD;&#xA;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Management/Treatment&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;ol style=&quot;list-style-type: decimal;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Interventions following anterior cruciate ligament (ACL) reconstruction&#xD;&#xA;    &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;        &lt;li&gt;Continuous passive motion &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Early weight bearing &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Functional knee bracing &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Immediate versus delayed mobilization &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Cryotherapy &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Supervised rehabilitation &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Therapeutic exercises (weight-bearing and non-weight-bearing concentric and eccentric exercises) &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Neuromuscular electrical stimulation &lt;/li&gt;&#xD;&#xA;        &lt;li&gt;Neuromuscular re-education &lt;/li&gt;&#xD;&#xA;    &lt;/ul&gt;&#xD;&#xA;    &lt;/li&gt;&#xD;&#xA;&lt;/ol&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="134" OrdBy="440" ID="404" Name="Major Outcomes Considered" Type="text">
      <FieldValue Value="&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Knee laxity and instability &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Range of motion &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Muscle strength &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Activity limitation &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Lower-limb coordination &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Global knee function &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;Return to activities &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;" />
    </Field>
  </Section>
  <Section SecID="405" OrdBy="500" Name="Methodology">
    <Field FieldID="109" OrdBy="505" ID="406" Name="Methods Used to Collect/Select the Evidence" Type="picklist-many">
      <FieldValue Value="Searches of Electronic Databases" />
    </Field>
    <Field FieldID="135" OrdBy="510" ID="407" Name="Description of Methods Used to Collect/Select the Evidence" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The authors of this guideline revision worked with research librarians with expertise in systematic reviews to perform a systematic search for concepts associated with ligament injuries and instabilities of the knee for articles published since 2008 related to classification, examination, and intervention strategies consistent with previous guideline development methods related to International Classification of Functioning, Disability and Health (ICF) classification. Briefly, the following databases were searched from 2008 to December 2016: MEDLINE (PubMed; 2008 to date), Scopus (Elsevier; 2008 to date), CINAHL (EBSCO; 2008 to date), SPORTDiscus (EBSCO; 2008 to date), Cochrane Library (Wiley; 2008 to date). (See Appendix A in the original guideline document for full search strategies and Appendix B for search dates and results.) &lt;/p&gt;&#xD;&#xA;&lt;p&gt;Articles contributing to recommendations were reviewed based on specified inclusion and exclusion criteria with the goal of identifying evidence relevant to physical therapist clinical decision making for adult persons with knee stability and movement coordination impairments/knee ligament sprain. The title and abstract of each article were reviewed independently by 2 members of the clinical practice guideline (CPG) development team for inclusion (see Appendix C in the original guideline document for inclusion and exclusion criteria). Full-text review was then similarly conducted to obtain the final set of articles for contribution to the recommendations. The team leader provided the final decision for discrepancies that were not resolved by the review team. For selected relevant topics that were not appropriate for the development of recommendations, such as incidence and imaging, articles were not subject to systematic review and were not included in the flow chart.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="136" OrdBy="515" ID="408" Name="Number of Source Documents" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Relevant articles appraised n = 248&#xA;&lt;/p&gt;&#xA;&lt;p&gt;See Appendix D in the original guideline document for a flow chart of articles and Appendix E for articles included in recommendations by topic.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="115" OrdBy="520" ID="409" Name="Methods Used to Assess the Quality and Strength of the Evidence" Type="picklist-choice">
      <FieldValue Value="Weighting According to a Rating Scheme (Scheme Given)" />
    </Field>
    <Field FieldID="149" OrdBy="525" ID="410" Name="Rating Scheme for the Strength of the Evidence" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Levels of Evidence&lt;/span&gt;&lt;/strong&gt;*&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;3&quot; cellpadding=&quot;5&quot; summary=&quot;Table: Levels of Evidence&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Level&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Intervention/Prevention&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Pathoanatomic/Risk/Clinical Course/Prognosis/Differential Diagnosis&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Diagnosis/Diagnostic Accuracy&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Prevalence of Condition/Disorder&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Exam/Outcomes&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;row&quot;&gt;&lt;strong&gt;I&lt;/strong&gt;&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of high-quality RCTs &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality RCT&lt;sup&gt;&amp;dagger;&lt;/sup&gt; &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of prospective cohort studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality prospective cohort study&lt;sup&gt;&amp;Dagger;&lt;/sup&gt; &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of high-quality diagnostic studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality diagnostic study&lt;sup&gt;&amp;sect;&lt;/sup&gt; with validation &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR, high-quality cross-sectional studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality cross-sectional study&lt;sup&gt;â &lt;/sup&gt;&lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of prospective cohort studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality prospective cohort study &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;row&quot;&gt;&lt;strong&gt;II&lt;/strong&gt;&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of high-quality cohort studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality cohort study&lt;sup&gt;&amp;Dagger;&lt;/sup&gt; &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Outcomes study or ecological study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Lower-quality RCT&lt;sup&gt;&amp;para;&lt;/sup&gt; &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of retrospective cohort study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Lower-quality prospective cohort study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality retrospective cohort study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Consecutive cohort &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Outcomes study or ecological study &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of exploratory diagnostic studies or consecutive cohort studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality exploratory diagnostic studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Consecutive retrospective cohort &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of studies that allows relevant estimate &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Lower-quality cross-sectional study &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SR of lower-quality prospective cohort studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Lower-quality prospective cohort study &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;row&quot;&gt;&lt;strong&gt;III &lt;/strong&gt;&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;SRs of case-control studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality case-control study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Lower-quality cohort study &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Lower-quality retrospective cohort study &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;High-quality cross-sectional case-control study &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;&#xD;&#xA;            &lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;                &lt;li&gt;Lower-quality exploratory diagnostic studies &lt;/li&gt;&#xD;&#xA;                &lt;li&gt;Nonconsecutive retrospective cohort &lt;/li&gt;&#xD;&#xA;            &lt;/ul&gt;&#xD;&#xA;            &lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Local nonrandom study&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;High-quality cross-sectional study&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;row&quot;&gt;&lt;strong&gt;IV&lt;/strong&gt;&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Case series&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Case series&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Case-control study&lt;/td&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;--&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Lower-quality cross-sectional study&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;row&quot;&gt;&lt;strong&gt;V&lt;/strong&gt;&lt;/th&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Expert opinion&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Expert opinion&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Expert opinion&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Expert opinion&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Expert opinion&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;Abbreviations: RCT, randomized clinical trial; SR, systematic review. &lt;/p&gt;&#xD;&#xA;&lt;p class=&quot;Note&quot;&gt;*Adapted from Phillips B, Ball C, Sackett D, et al. Oxford Centre for Evidence-based Medicine - Levels of Evidence (March 2009). Available at: &lt;a href=&quot;http://www.cebm.net/index.aspx?o=1025&quot; title=&quot;Center for Evidence Based Medicine Web site&quot;&gt;http://www.cebm.net/index.aspx?o=1025&lt;/a&gt;. See also Appendix G in the original guideline document.&lt;br /&gt;&#xD;&#xA;&amp;dagger;High quality includes RCTs with greater than 80% follow-up, blinding, and appropriate randomization procedures.&lt;br /&gt;&#xD;&#xA;&amp;Dagger;High-quality cohort study includes greater than 80% follow-up.&lt;br /&gt;&#xD;&#xA;&amp;sect;High-quality diagnostic study includes consistently applied reference standard and blinding.&lt;br /&gt;&#xD;&#xA;âHigh-quality prevalence study is a cross-sectional study that uses a local and current random sample or censuses.&lt;br /&gt;&#xD;&#xA;&amp;para;Weaker diagnostic criteria and reference standards, improper randomization, no blinding, and less than 80% follow-up may add bias and threats to validity.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="116" OrdBy="530" ID="411" Name="Methods Used to Analyze the Evidence" Type="picklist-many">
      <FieldValue Value="Review of Published Meta-Analyses" />
      <FieldValue Value="Systematic Review with Evidence Tables" />
    </Field>
    <Field FieldID="150" OrdBy="535" ID="412" Name="Description of the Methods Used to Analyze the Evidence" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Levels of Evidence&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Individual clinical research articles were graded according to criteria adapted from the Centre for Evidence-Based Medicine, Oxford, United Kingdom for diagnostic, prospective, and therapeutic studies. In 3 teams of 2, each reviewer independently assigned a level of evidence and evaluated the quality of each article using a critical appraisal tool. See the &quot;Rating Scheme for the Strength of Evidence&quot; field for the levels of evidence table and Appendix G in the original guideline document for details on procedures used for assigning levels of evidence. The evidence update was organized from highest level of evidence to lowest level.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="112" OrdBy="540" ID="413" Name="Methods Used to Formulate the Recommendations" Type="picklist-choice">
      <FieldValue Value="Expert Consensus" />
    </Field>
    <Field FieldID="145" OrdBy="545" ID="414" Name="Description of Methods Used to Formulate the Recommendations" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Content experts were appointed by the Orthopaedic Section of the American Physical Therapy Association (APTA) to conduct a review of the literature and to develop an updated &quot;Knee Stability and Movement Coordination Impairments: Knee Ligament Sprain&quot; clinical practice guideline (CPG) as indicated by the current state of the evidence in the field. The aims of the revision were to provide a concise summary of the evidence since publication of the original guideline and to develop new recommendations or revise previously published recommendations to support evidence-based practice. &lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Grades of Evidence&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;The strength of the evidence supporting the recommendations was graded according to the previously established methods for the 2010 guideline and those provided in the original guideline document. Each team developed recommendations based on the strength of evidence, including how directly the studies addressed the question on knee stability and movement coordination impairments/ knee ligament sprain population. In developing their recommendations, the authors considered the strengths and limitations of the body of evidence and the health benefits, side effects, and risks of tests and interventions.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="146" OrdBy="550" ID="415" Name="Rating Scheme for the Strength of the Recommendations" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;strong&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;Grades of Recommendation Based on Strength of Evidence&lt;/span&gt;&lt;/strong&gt;&lt;/p&gt;&#xD;&#xA;&lt;table border=&quot;1&quot; cellspacing=&quot;3&quot; cellpadding=&quot;5&quot; summary=&quot;Table: Grades of Recommendation&quot;&gt;&#xD;&#xA;    &lt;thead&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; colspan=&quot;2&quot; scope=&quot;col&quot;&gt;Grades of Recommendation Based On&lt;/th&gt;&#xD;&#xA;            &lt;th class=&quot;Center&quot; valign=&quot;top&quot; scope=&quot;col&quot;&gt;Strength of Evidence&lt;/th&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/thead&gt;&#xD;&#xA;    &lt;tbody&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;A&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Strong evidence&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A preponderance of level I and/or level II studies support the recommendation. This must include at least 1 level I study&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;B&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Moderate evidence&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A single high-quality randomized controlled trial or a preponderance of level II studies support the recommendation&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;C&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Weak evidence&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A single level II study or a preponderance of level III and IV studies, including statements of consensus by content experts, support the recommendation&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;D&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Conflicting evidence&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Higher-quality studies conducted on this topic disagree with respect to their conclusions. The recommendation is based on these conflicting studies&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;E&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Theoretical/foundational evidence&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;A preponderance of evidence from animal or cadaver studies, from conceptual models/principles, or from basic sciences/bench research support this conclusion&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;        &lt;tr&gt;&#xD;&#xA;            &lt;td class=&quot;Center&quot; valign=&quot;top&quot;&gt;F&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Expert opinion&lt;/td&gt;&#xD;&#xA;            &lt;td valign=&quot;top&quot;&gt;Best practice based on the clinical experience of the guidelines development team&lt;/td&gt;&#xD;&#xA;        &lt;/tr&gt;&#xD;&#xA;    &lt;/tbody&gt;&#xD;&#xA;&lt;/table&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="148" OrdBy="565" ID="417" Name="Cost Analysis" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;A formal cost analysis was not performed and published cost analyses were not reviewed.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="104" OrdBy="570" ID="418" Name="Method of Guideline Validation" Type="picklist-choice">
      <FieldValue Value="External Peer Review" />
      <FieldValue Value="Internal Peer Review" />
    </Field>
    <Field FieldID="130" OrdBy="575" ID="419" Name="Description of Method of Guideline Validation" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Guideline Review Process and Validation&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Identified reviewers who are experts in knee ligament injury management and rehabilitation reviewed the content and methods of this clinical practice guideline (CPG) for integrity, accuracy, and to ensure that it fully represents the condition. Any comments, suggestions, or feedback from the expert reviewers were delivered to the authors and editors to consider and make appropriate revisions. These guidelines were also posted for public comment and review on the orthopt.org Web site, and a notification of this posting was sent to the members of the Orthopaedic Section, American Physical Therapy Association (APTA), Inc. Any comments, suggestions, and feedback gathered from public commentary were sent to the authors and editors to consider and make appropriate revisions in the guideline. In addition, a panel of consumer/patient representatives and external stakeholders, such as claims reviewers, medical coding experts, academic educators, clinical educators, physician specialists, and researchers, also reviewed the guideline and provided feedback and recommendations that were given to the authors and editors for further consideration and revisions. Last, a panel of consumer/patient representatives and external stakeholders and a panel of experts in physical therapy practice guideline methodology annually review the Orthopaedic Section, APTA's International Classification of Functioning, Disability and Health (ICF)-based Clinical Practice Guideline Policies and provide feedback and comments to the Clinical Practice Guideline Coordinator and Editors to improve the APTA's guideline development and implementation processes. &lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="424" OrdBy="600" Name="Evidence Supporting the Recommendations">
    <Field FieldID="139" OrdBy="610" ID="426" Name="Type of Evidence Supporting the Recommendations" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The type of supporting evidence is identified and graded for each recommendation (see &quot;Major Recommendations&quot; field).&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="427" OrdBy="700" Name="Benefits/Harms of Implementing the Guideline Recommendations">
    <Field FieldID="152" OrdBy="705" ID="428" Name="Potential Benefits" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Improvement in scores on validated outcome measurement scales&lt;/p&gt;&#xD;&#xA;&lt;p&gt;Refer to the &quot;Evidence Update&quot; section in the original guideline document for specific benefits of the interventions. &lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="153" OrdBy="710" ID="429" Name="Potential Harms" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Refer to the &quot;Evidence Update&quot; sections of the original guideline document for specific harms of interventions.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="432" OrdBy="900" Name="Qualifying Statements">
    <Field FieldID="137" OrdBy="905" ID="433" Name="Qualifying Statements" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Statement of Intent&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;These guidelines are not intended to be construed or to serve as a standard of medical care. Standards of care are determined on the basis of all clinical data available for an individual patient and are subject to change as scientific knowledge and technology advance and patterns of care evolve. These parameters of practice should be considered guidelines only. Adherence to them will not ensure a successful outcome in every patient, nor should they be construed as including all proper methods of care or excluding other acceptable methods of care aimed at the same results. The ultimate judgment regarding a particular clinical procedure or treatment plan must be made based on clinician experience and expertise in light of the clinical presentation of the patient, the available evidence, available diagnostic and treatment options, and the patient's values, expectations, and preferences. However, it is suggested that significant departures from accepted guidelines should be documented in the patient's medical records at the time the relevant clinical decision is made.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="434" OrdBy="1000" Name="Implementation of the Guideline">
    <Field FieldID="131" OrdBy="1010" ID="436" Name="Description of Implementation Strategy" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;span style=&quot;text-decoration: underline;&quot;&gt;&lt;strong&gt;Dissemination and Implementation Tools&lt;/strong&gt;&lt;/span&gt;&lt;/p&gt;&#xD;&#xA;&lt;p&gt;In addition to publishing these guidelines in the &lt;em&gt;Journal of Orthopaedic &amp;amp; Sports Physical Therapy&lt;/em&gt; (&lt;em&gt;JOSPT&lt;/em&gt;), these guidelines will be posted on clinical practice guideline (CPG) areas of both the &lt;em&gt;JOSPT&lt;/em&gt; and the Orthopaedic Section, American Physical Therapy Association (APTA) Web sites for free access, and will be submitted for posting on the Agency for Healthcare Research and Quality Web site (&lt;a href=&quot;http://www.guideline.gov&quot; title=&quot;National Guideline Clearinghouse Web site&quot; target=&quot;_blank&quot;&gt;www.guideline.gov&lt;/a&gt;). The implementation tools planned to be available for patients, clinicians, educators, payers, policy makers, and researchers, and the associated implementation strategies, are listed in a table in the original guideline document.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="117" OrdBy="1015" ID="437" Name="Implementation Tools" Type="picklist-many">
      <FieldValue Value="Patient Resources" />
      <FieldValue Value="Resources" />
    </Field>
  </Section>
  <Section SecID="439" OrdBy="1100" Name="Institute of Medicine (IOM) National Healthcare Quality Report Categories">
    <Field FieldID="50" OrdBy="1105" ID="440" Name="IOM Care Need" Type="picklist-many">
      <FieldValue Value="Getting Better" />
      <FieldValue Value="Living with Illness" />
    </Field>
    <Field FieldID="51" OrdBy="1110" ID="441" Name="IOM Domain" Type="picklist-many">
      <FieldValue Value="Effectiveness" />
      <FieldValue Value="Patient-centeredness" />
    </Field>
  </Section>
  <Section SecID="442" OrdBy="1200" Name="Identifying Information and Availability">
    <Field FieldID="97" OrdBy="1201" ID="392" Name="Bibliographic Source(s)" Type="citation">
      <FieldValue Value="&lt;table&gt;&lt;tr&gt;&lt;td&gt;Logerstedt DS, Scalzitti D, Risberg MA, Engebretsen L, Webster KE, Feller J, Snyder-Mackler L, Axe MJ, McDonough CM. Knee stability and movement coordination impairments: knee ligament sprain revision 2017. J Orthop Sports Phys Ther. 2017 Nov;47(11):A1-A47. [129 references] &lt;a href=&quot;http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=29089004 &quot; target=&quot;_blank&quot;&gt;PubMed&lt;/a&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;" />
    </Field>
    <Field FieldID="124" OrdBy="1205" ID="443" Name="Adaptation" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Not applicable: The guideline was not adapted from another source.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="128" OrdBy="1215" ID="445" Name="Date Released" Type="text">
      <FieldValue Value="2017 Nov" />
    </Field>
    <Field FieldID="158" OrdBy="1225" ID="447" Name="Guideline Developer(s)" Type="orglist-p">
      <FieldValue Value="American Physical Therapy Association, Inc., The Orthopaedic Section - Medical Specialty Society" />
    </Field>
    <Field FieldID="125" OrdBy="1235" ID="449" Name="Source(s) of Funding" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The Orthopaedic Section of the American Physical Therapy Association (APTA), Inc.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="126" OrdBy="1240" ID="450" Name="Guideline Committee" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Clinical Practice Guideline (CPG) Development Team&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="127" OrdBy="1245" ID="451" Name="Composition of Group That Authored the Guideline" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;&lt;em&gt;Authors&lt;/em&gt;: David S. Logerstedt, PT, PhD, Assistant Professor, Department of Physical Therapy, University of the Sciences, Philadelphia, PA; David Scalzitti, PT, PhD, Assistant Professor, Department of Physical Therapy, George Washington University, Washington, DC; May Arna Risberg, PT, PhD, Chair, Norwegian Research Center for Active Rehabilitation, Oslo, Norway and Professor, Department of Sports Medicine, Norwegian School of Sport Sciences, Oslo, Norway; Lars Engebretsen, MD, Oslo Sports Trauma Research Center, Norwegian School of Sport Sciences, Oslo, Norway and Department of Orthopaedics, Oslo University Hospital, Oslo, Norway; Kate E. Webster, PhD, Associate Professor, School of Allied Health, La Trobe University, Melbourne, Australia; Julian Feller, MD, OrthoSport Victoria Research Unit, Deakin University and Epworth Healthcare, Melbourne, Australia; Lynn Snyder-Mackler, PT, ScD, Alumni Distinguished Professor, Department of Physical Therapy and Faculty Athletics Representative, University of Delaware, Newark, DE; Michael J. Axe, MD, First State Orthopaedics, Newark, DE; Christine M. McDonough, PT, PhD, ICF-Based Clinical Practice Guidelines Editor, Orthopaedic Section, APTA, Inc, La Crosse, WI and Adjunct Clinical Assistant Professor, Department of Orthopaedic Surgery, Geisel School of Medicine at Dartmouth, Dartmouth-Hitchcock Medical Center, Lebanon, NH and Research Assistant Professor, Health and Disability Research Institute, Boston University School of Public Health, Boston, MA&lt;/p&gt;&#xD;&#xA;&lt;p&gt;&lt;em&gt;Reviewers&lt;/em&gt;: Roy D. Altman, MD, Professor of Medicine, Division of Rheumatology and Immunology, David Geffen School of Medicine at UCLA, Los Angeles, CA; Paul Beattie, PT, PhD, Clinical Professor, Division of Rehabilitative Sciences, University of South Carolina, Columbia, SC; John DeWitt, DPT, Director, Physical Therapy Sports and Orthopaedic Residencies, The Ohio State University, Columbus, OH; James M. Elliott, PT, PhD, Assistant Professor, Northwestern University Physical Therapy and Human Movement Sciences, Feinberg School of Medicine, Northwestern University, Chicago, IL; Amanda Ferland, DPT, Clinical Faculty, Intech Rehabilitation Group/Division of Biokinesiology and Physical Therapy, Orthopaedic Physical Therapy Residency, University of Southern California, Los Angeles, CA and Spine Rehabilitation Fellowship, Beijing, China; G. Kelley Fitzgerald, PT, PhD, Professor and Associate Dean of Graduate Studies, School of Health and Rehabilitation Sciences and Director, Physical Therapy Clinical and Translational Research Center, University of Pittsburgh, Pittsburgh, PA; Sandra Kaplan, PT, PhD, Clinical Practice Guidelines Coordinator, Pediatric Section, APTA, Inc, Alexandria, VA and Professor, Doctoral Programs in Physical Therapy, Rutgers University, Newark, NJ; David Killoran, PhD, Patient/Consumer Representative, ICF-Based Clinical Practice Guidelines, Orthopaedic Section, APTA, Inc, La Crosse, WI and Professor Emeritus, Loyola Marymount University, Los Angeles, CA; Joanna Kvist, PT, PhD, Professor, Department of Medical and Health Sciences, Division of Physiotherapy, Link&amp;ouml;ping University, Link&amp;ouml;ping, Sweden; Robert Marx, MD, MSc, Department of Orthopaedics, Hospital for Special Surgery, New York, NY; Leslie Torburn, DPT, Principal and Consultant, Silhouette Consulting, Inc, Sacramento, CA; James Zachazewski, DPT, Clinical Director, Department of Physical and Occupational Therapy, Massachusetts General Hospital, Boston, MA and Clinical Content Lead, Health Professions, Partners eCare, Boston, MA and Adjunct Assistant Clinical Professor, Program in Physical Therapy, MGH Institute of Health Professions, Charlestown, MA&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="147" OrdBy="1250" ID="452" Name="Financial Disclosures/Conflicts of Interest" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The authors declared relationships and developed a conflict&#xA;management plan, which included submitting a Conflict of&#xA;Interest form to the Orthopaedic Section, American Physical Therapy Association (APTA), Inc. Articles that were authored by a reviewer were assigned to an alternate&#xA;reviewer. Funding was provided to the clinical practice guideline (CPG) development team&#xA;for travel and expenses for CPG development training. The&#xA;CPG development team maintained editorial independence.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="120" OrdBy="1256" ID="393" Name="Guideline Status" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This is the current release of the guideline.&lt;/p&gt;&#xA;&lt;p&gt;This guideline update a previous version: Logerstedt DS, Snyder-Mackler L, Ritter RC, Axe MJ, Godges JJ, Orthopaedic Section of the American Physical Therapist Association. Knee stability and movement coordination impairments: knee ligament sprain. J Orthop Sports Phys Ther. 2010 Apr;40(4):A1-A37. [175 references]. &lt;/p&gt;&#xA;&lt;p&gt;This guideline meets NGC's 2013 (revised) inclusion criteria.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="118" OrdBy="1260" ID="454" Name="Guideline Availability" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;Available from the &lt;a title=&quot;American Physical Therapy Association, Inc., Orthopedic Section Web site&quot; href=&quot;https://www.orthopt.org/uploads/content_files/files/Knee%20Ligament%20Sprain%20CPG%20-%202017.pdf&quot;&gt;American Physical Therapy Association, Inc., Orthopedic Section Web site&lt;/a&gt;.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="119" OrdBy="1265" ID="455" Name="Availability of Companion Documents" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following are available: &lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Knee ligament sprain: clinical practice guidelines revision 2017. Decision tree. J Orthop Sports Phys Ther. 2017 Nov; 47(11). Available from the &lt;a href=&quot;https://www.orthopt.org/uploads/content_files/files/Knee%20Sprain%20Revision%20Decision%20Tree%20and%20Components%281%29.pdf&quot; title=&quot;American Physical Therapy Association, Inc., Orthopedic Section Web site&quot;&gt;American Physical Therapy Association, Inc., Orthopedic Section Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;    &lt;li&gt;APTA clinical practice guideline process manual. Alexandria (VA): American Physical Therapy Association (APTA); 2018. 63 p. Available from the &lt;a href=&quot;http://www.apta.org/uploadedFiles/APTAorg/Practice_and_Patient_Care/Evidence_and_Research/Evidence_Tools/Components_of_EBP/CPGs/APTACPGManual2018.pdf&quot; title=&quot;APTA Web site&quot;&gt;APTA Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="143" OrdBy="1275" ID="457" Name="Patient Resources" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;The following is available:&lt;/p&gt;&#xD;&#xA;&lt;ul style=&quot;list-style-type: disc;&quot;&gt;&#xD;&#xA;    &lt;li&gt;Knee ligament sprains and tears: clinical practice guidelines&amp;mdash;ensuring best care. JOSPT perspectives for patients. J Orthop Sports Phys Ther 2017;47(11):824. Available from the &lt;a href=&quot;https://www.jospt.org/doi/pdf/10.2519/jospt.2017.0511&quot; title=&quot;Journal of Orthopaedic &amp;amp; Sports Physical Therapy Web site&quot;&gt;Journal of Orthopaedic &amp;amp; Sports Physical Therapy Web site&lt;/a&gt;. &lt;/li&gt;&#xD;&#xA;&lt;/ul&gt;&#xD;&#xA;&lt;p class=&quot;Disclaimer&quot;&gt;Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="142" OrdBy="1280" ID="458" Name="NGC Status" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary was completed by ECRI Institute on May 13, 2011. This summary was updated by ECRI Institute on March 19, 2018. The information was verified by the guideline developer on April 6, 2018. &lt;/p&gt;&#xD;&#xA;&lt;p&gt;This NEATS assessment was completed by ECRI Institute on March 14, 2018. The information was verified by the guideline developer on April 6, 2018. &lt;/p&gt;&lt;/div&gt;" />
    </Field>
    <Field FieldID="141" OrdBy="1290" ID="460" Name="Copyright Statement" Type="text">
      <FieldValue Value="&lt;div class=&quot;content_para&quot;&gt;&lt;p&gt;This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions.&lt;/p&gt;&lt;/div&gt;" />
    </Field>
  </Section>
  <Section SecID="99999" OrdBy="99999" Name="Disclaimer">
    <Field FieldID="99999" OrdBy="99999" ID="99999" Name="NGC Disclaimer" Type="text">
      <FieldValue Value="&lt;p&gt;The National Guideline Clearinghouseâ¢ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the &lt;a href=&quot;/help-and-about/summaries/inclusion-criteria&quot;&gt;NGC Inclusion Criteria&lt;/a&gt;.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.&lt;/p&gt; &#xD;&#xA;&lt;p&gt;Readers with questions regarding guideline content are directed to contact the guideline developer.&lt;/p&gt;" />
    </Field>
  </Section>
</Version>